BACKGROUND Breast cancer is the most common malignancy in women all around the world.According to the latest statistics in 2018,there were more than 2.08 million new breast cancer cases all around the world and more t...BACKGROUND Breast cancer is the most common malignancy in women all around the world.According to the latest statistics in 2018,there were more than 2.08 million new breast cancer cases all around the world and more than 620000 deaths;the proportion of breast cancer deaths in women with cancer is 15%.By studying age,clinicopathological characteristics and molecular classification,age at menarche,age at birth,number of births,number of miscarriages,lactation time,surgical history of benign breast lesions,history of gynecological diseases,and other factors,we retrospectively summarized and compared the disease history of patients with primary breast cancer and patients with benign thyroid tumors admitted to our hospital in the past 10 years to explore the clinicopathological characteristics and risk factors for primary breast cancer.AIM To investigate the clinical and pathological features and risk factors for primary breast cancer treated at our center in order to provide a reference for the prevention and treatment of breast cancer in the Zhuhai-Macao region.METHODS Through a retrospective case-control study,149 patients with primary breast cancer diagnosed and treated at Zhuhai Hospital of Guangdong Provincial Hospital of Traditional Chinese Medicine from January 2013 to March 2020 were included as a case group,and 165 patients with benign breast tumors diagnosed and treated from January 2019 to March 2020 were included as a control group.The data collected included age,age at menarche,age at first birth,number of births,number of miscarriages,lactation time,history of surgery for benign breast lesions,history of familial malignant tumors,history of gynecological diseases,history of thyroid diseases,and the tumor characteristics of the patients in the case group including pathological diagnosis,pathological type,tumor size,lymph node metastasis,distant metastasis,stage,and molecular classification,among others.In the case group,the chi-square test was used to analyze the clinical and pathological features of patients in three age groups(<40,40-59,and≥60 years).A multifactor logistic regression analysis was used to analyze correlations between the two groups.RESULTS Among 149 patients with primary breast cancer,the average age was 48.20±12.06 years,and the proportion of patients at 40-59 years old was the highest,accounting for 61.8%of cases.The molecular type was mainly luminal B type,accounting for 69.2%of cases,and at the time of diagnosis,the tumor stage was mainly stage I/II,accounting for 62.4%of cases.There were no statistically significant differences in the distributions of tumor location,pathological type,tumor size,lymph node metastasis,stage,or molecular classification among the three age groups(<40,40-59,and≥60 years)(P≥0.05).The differences in the distribution of distant metastasis among the three age groups(<40,40-59,and≥60 years)were statistically significant(P<0.01).The differences in lactation time,history of familial malignant tumors,history of gynecological diseases,and history of thyroid diseases between the two groups were not statistically significant(P≥0.05).The differences in age at disease diagnosis,age at menarche,and history of surgery for benign breast lesions were statistically significant(P<0.01).The difference in age at first birth was also statistically significant(P<0.05).CONCLUSION The highest incidence of breast cancer in the Zhuhai-Macao region is present among women aged 40-59 years.There is a larger proportion of stage I/II patients,and the luminal B type is the most common molecular subtype.Distant metastasis occurs mainly in the≥60-year-old group at the first diagnosis;increased age,late age at menarche,and late age at first birth may be risk factors for primary breast cancer,and a history of surgery for benign breast lesions may be a protective factor for primary breast cancer.展开更多
目的探讨脾部分栓塞术联合肝动脉化疗栓塞术在原发性肝癌伴脾功能亢进中的临床疗效及应用价值。方法80例原发性肝癌伴脾功能亢进患者,采用简单化随机法将所有患者分为对照组和实验组,每组40例。对照组患者实施肝动脉化疗栓塞术,实验组...目的探讨脾部分栓塞术联合肝动脉化疗栓塞术在原发性肝癌伴脾功能亢进中的临床疗效及应用价值。方法80例原发性肝癌伴脾功能亢进患者,采用简单化随机法将所有患者分为对照组和实验组,每组40例。对照组患者实施肝动脉化疗栓塞术,实验组患者在对照组的基础上联合脾部分栓塞术。比较两组患者临床疗效、不良反应发生情况以及手术前后谷丙转氨酶(ALT)、总胆红素(TBIL)、白细胞计数(WBC)、血小板计数(PLT)、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)。结果实验组治疗总有效率95.0%高于对照组的77.5%,差异具有统计学意义(P<0.05)。实验组患者术前ALT为(55.57±8.56)U/L、TBIL为(24.25±3.12)μmol/L,术后7 d ALT为(33.27±4.08)U/L、TBIL为(17.58±2.15)μmol/L;对照组患者术前ALT为(55.29±8.37)U/L、TBIL为(24.64±3.15)μmol/L,术后7 d ALT为(49.68±6.65)U/L、TBIL为(22.12±2.86)μmol/L。与术前比较,术后7 d两组患者ALT、TBIL水平均有所改善,且与对照组比较,实验组患者的ALT、TBIL水平改善效果更明显,均恢复至正常水平,差异具有统计学意义(P<0.05)。实验组患者术前WBC为(2.48±0.26)×10^(9)/L、PLT为(64.36±10.15)×10^(9)/L,术后7 d WBC为(6.57±1.18)×10^(9)/L、PLT为(117.38±18.15)×10^(9)/L;对照组患者术前WBC为(2.39±0.18)×10^(9)/L、PLT为(64.51±10.22)×10^(9)/L,术后7dWBC为(3.68±0.53)×10^(9)/L、PLT为(83.16±12.86)×10^(9)/L。与术前比较,术后7 d两组患者的WBC、PLT水平均有所升高,且与对照组比较,实验组患者的WBC、PLT水平升高幅度更明显,均恢复至正常水平,差异具有统计学意义(P<0.05)。实验组患者术前PT为(19.26±2.24)s、APTT为(54.35±8.12)s,术后7 d PT为(10.27±1.88)s、APTT为(31.63±4.15)s;对照组患者术前PT为(19.29±2.26)s、APTT为(54.26±8.10)s,术后7 d PT为(16.56±2.05)s、APTT为(44.32±6.86)s。与术前比较,术后7 d两组患者的PT、APTT均有所缩短,且与对照组比较,实验组患者PT、APTT缩短幅度更明显,均恢复至正常水平,差异具有统计学意义(P<0.05)。两组患者术中、术后均未出现严重不良反应,实验组不良反应发生率7.5%低于对照组的27.5%(P<0.05)。结论肝动脉化疗栓塞术联合脾部分栓塞术能够有效改善原发性肝癌伴脾功能亢进患者的肝功能、血常规,促进患者的凝血功能恢复,且安全性良好,值得临床推广应用。展开更多
文摘BACKGROUND Breast cancer is the most common malignancy in women all around the world.According to the latest statistics in 2018,there were more than 2.08 million new breast cancer cases all around the world and more than 620000 deaths;the proportion of breast cancer deaths in women with cancer is 15%.By studying age,clinicopathological characteristics and molecular classification,age at menarche,age at birth,number of births,number of miscarriages,lactation time,surgical history of benign breast lesions,history of gynecological diseases,and other factors,we retrospectively summarized and compared the disease history of patients with primary breast cancer and patients with benign thyroid tumors admitted to our hospital in the past 10 years to explore the clinicopathological characteristics and risk factors for primary breast cancer.AIM To investigate the clinical and pathological features and risk factors for primary breast cancer treated at our center in order to provide a reference for the prevention and treatment of breast cancer in the Zhuhai-Macao region.METHODS Through a retrospective case-control study,149 patients with primary breast cancer diagnosed and treated at Zhuhai Hospital of Guangdong Provincial Hospital of Traditional Chinese Medicine from January 2013 to March 2020 were included as a case group,and 165 patients with benign breast tumors diagnosed and treated from January 2019 to March 2020 were included as a control group.The data collected included age,age at menarche,age at first birth,number of births,number of miscarriages,lactation time,history of surgery for benign breast lesions,history of familial malignant tumors,history of gynecological diseases,history of thyroid diseases,and the tumor characteristics of the patients in the case group including pathological diagnosis,pathological type,tumor size,lymph node metastasis,distant metastasis,stage,and molecular classification,among others.In the case group,the chi-square test was used to analyze the clinical and pathological features of patients in three age groups(<40,40-59,and≥60 years).A multifactor logistic regression analysis was used to analyze correlations between the two groups.RESULTS Among 149 patients with primary breast cancer,the average age was 48.20±12.06 years,and the proportion of patients at 40-59 years old was the highest,accounting for 61.8%of cases.The molecular type was mainly luminal B type,accounting for 69.2%of cases,and at the time of diagnosis,the tumor stage was mainly stage I/II,accounting for 62.4%of cases.There were no statistically significant differences in the distributions of tumor location,pathological type,tumor size,lymph node metastasis,stage,or molecular classification among the three age groups(<40,40-59,and≥60 years)(P≥0.05).The differences in the distribution of distant metastasis among the three age groups(<40,40-59,and≥60 years)were statistically significant(P<0.01).The differences in lactation time,history of familial malignant tumors,history of gynecological diseases,and history of thyroid diseases between the two groups were not statistically significant(P≥0.05).The differences in age at disease diagnosis,age at menarche,and history of surgery for benign breast lesions were statistically significant(P<0.01).The difference in age at first birth was also statistically significant(P<0.05).CONCLUSION The highest incidence of breast cancer in the Zhuhai-Macao region is present among women aged 40-59 years.There is a larger proportion of stage I/II patients,and the luminal B type is the most common molecular subtype.Distant metastasis occurs mainly in the≥60-year-old group at the first diagnosis;increased age,late age at menarche,and late age at first birth may be risk factors for primary breast cancer,and a history of surgery for benign breast lesions may be a protective factor for primary breast cancer.
文摘目的探讨脾部分栓塞术联合肝动脉化疗栓塞术在原发性肝癌伴脾功能亢进中的临床疗效及应用价值。方法80例原发性肝癌伴脾功能亢进患者,采用简单化随机法将所有患者分为对照组和实验组,每组40例。对照组患者实施肝动脉化疗栓塞术,实验组患者在对照组的基础上联合脾部分栓塞术。比较两组患者临床疗效、不良反应发生情况以及手术前后谷丙转氨酶(ALT)、总胆红素(TBIL)、白细胞计数(WBC)、血小板计数(PLT)、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)。结果实验组治疗总有效率95.0%高于对照组的77.5%,差异具有统计学意义(P<0.05)。实验组患者术前ALT为(55.57±8.56)U/L、TBIL为(24.25±3.12)μmol/L,术后7 d ALT为(33.27±4.08)U/L、TBIL为(17.58±2.15)μmol/L;对照组患者术前ALT为(55.29±8.37)U/L、TBIL为(24.64±3.15)μmol/L,术后7 d ALT为(49.68±6.65)U/L、TBIL为(22.12±2.86)μmol/L。与术前比较,术后7 d两组患者ALT、TBIL水平均有所改善,且与对照组比较,实验组患者的ALT、TBIL水平改善效果更明显,均恢复至正常水平,差异具有统计学意义(P<0.05)。实验组患者术前WBC为(2.48±0.26)×10^(9)/L、PLT为(64.36±10.15)×10^(9)/L,术后7 d WBC为(6.57±1.18)×10^(9)/L、PLT为(117.38±18.15)×10^(9)/L;对照组患者术前WBC为(2.39±0.18)×10^(9)/L、PLT为(64.51±10.22)×10^(9)/L,术后7dWBC为(3.68±0.53)×10^(9)/L、PLT为(83.16±12.86)×10^(9)/L。与术前比较,术后7 d两组患者的WBC、PLT水平均有所升高,且与对照组比较,实验组患者的WBC、PLT水平升高幅度更明显,均恢复至正常水平,差异具有统计学意义(P<0.05)。实验组患者术前PT为(19.26±2.24)s、APTT为(54.35±8.12)s,术后7 d PT为(10.27±1.88)s、APTT为(31.63±4.15)s;对照组患者术前PT为(19.29±2.26)s、APTT为(54.26±8.10)s,术后7 d PT为(16.56±2.05)s、APTT为(44.32±6.86)s。与术前比较,术后7 d两组患者的PT、APTT均有所缩短,且与对照组比较,实验组患者PT、APTT缩短幅度更明显,均恢复至正常水平,差异具有统计学意义(P<0.05)。两组患者术中、术后均未出现严重不良反应,实验组不良反应发生率7.5%低于对照组的27.5%(P<0.05)。结论肝动脉化疗栓塞术联合脾部分栓塞术能够有效改善原发性肝癌伴脾功能亢进患者的肝功能、血常规,促进患者的凝血功能恢复,且安全性良好,值得临床推广应用。
